Literature DB >> 356965

Effect of hyperthermia on the immunocompetence of VX2 tumor-bearing rabbits.

S A Shah, J A Dickson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 356965

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  7 in total

1.  Hematologic and immunologic effects of nonionizing electromagnetic radiation.

Authors:  R J Smialowicz
Journal:  Bull N Y Acad Med       Date:  1979-12

2.  Delayed and Aberrant Presentation of VX2 Carcinoma in a Rabbit Model of Hepatic Neoplasia.

Authors:  Sarah A Hansen; Michael K Fink; Anandhi Upendran; Cynthia L Besch-Williford; Robert S Livingston; James M Amos-Landgraf; Jimmy C Lattimer; Raghuraman Kannan
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 3.  Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.

Authors:  Florentina Pascale; Jean-Pierre Pelage; Michel Wassef; Saïda H Ghegediban; Jean-Pierre Saint-Maurice; Thierry De Baere; Alban Denys; Rafael Duran; Frédéric Deschamps; Olivier Pellerin; Noboru Maeda; Alexandre Laurent; Julien Namur
Journal:  Front Oncol       Date:  2022-05-10       Impact factor: 5.738

4.  Enhancement of spontaneous and lymphokine activated human macrophage cytotoxicity by hyperthermia.

Authors:  R Andreesen; J Osterholz; A Schulz; G W Löhr
Journal:  Blut       Date:  1983-10

5.  Comparison of DMSO and glycerol as cryoprotectants for ascites tumor cells.

Authors:  S A Shah
Journal:  Experientia       Date:  1983-03-15

6.  Antigenic differences between a primary hamster lymphosarcoma and its liver metastases.

Authors:  G V Sherbet; M S Lakshmi; G P Risely; S A Shah; M E Tindle
Journal:  Experientia       Date:  1982-05-15

7.  Influence of tumour volume and cell kinetics on the response of the solid Yoshida sarcoma to hyperthermia (42 degrees C).

Authors:  S K Calderwood; J A Dickson
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.